VAX November 2016
Vol. 14, No. 06 – November 2016
- Category: VAX November 2016
Gerald Voss, former head of GlaxoSmithKline (GSK) Vaccine’s HIV Vaccine program and vice president of the Enterprise’s Board of Directors, is now interim director of the Global HIV Vaccine Enterprise Secretariat, replacing longtime AIDS vaccine advocate William Snow, who has stepped down.